UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 58

Sortiert nach

Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations

Lancet neurology, 2007-12, Vol.6 (12), p.1094-1105

2007

Volltextzugriff (PDF)

Definitions, diagnosis, and decompression in spinal surgery: problems and solution

The spine journal, 2015-03, Vol.15 (3), p.S5-S8

2015

Volltextzugriff (PDF)

MUltiple Sclerosis and Extract of Cannabis: results of the MUSEC trial

Journal of neurology, neurosurgery and psychiatry, 2012-11, Vol.83 (11), p.1125-1132

2012

Volltextzugriff (PDF)

Patient-orientated longitudinal study of multiple sclerosis in south west England (The South West Impact of Multiple Sclerosis Project, SWIMS) 1: protocol and baseline characteristics of cohort

BMC neurology, 2010-10, Vol.10 (1), p.88-88, Article 88

2010

Volltextzugriff (PDF)

What sample sizes for reliability and validity studies in neurology?

Journal of neurology, 2012-12, Vol.259 (12), p.2681-2694

2012

Volltextzugriff (PDF)

The ADAS-cog in Alzheimer's disease clinical trials: psychometric evaluation of the sum and its parts

Journal of neurology, neurosurgery and psychiatry, 2010-12, Vol.81 (12), p.1363-1368

2010

Volltextzugriff (PDF)

A tool to measure the attributes of receiving IV therapy in a home versus hospital setting: the Multiple Sclerosis Relapse Management Scale (MSRMS)

Health and quality of life outcomes, 2011-09, Vol.9 (1), p.80-80, Article 80

2011

Volltextzugriff (PDF)

The problem with health measurement

Patient preference and adherence, 2011-01, Vol.5 (default), p.279-290

2011

Volltextzugriff (PDF)

The cervical dystonia impact profile (CDIP-58): can a Rasch developed patient reported outcome measure satisfy traditional psychometric criteria?

Health and quality of life outcomes, 2008-08, Vol.6 (1), p.58-58, Article 58

2008

Volltextzugriff (PDF)

Patient-based outcomes of cervical dystonia: A review of rating scales

Movement disorders, 2004-09, Vol.19 (9), p.1054-1059

2004

Volltextzugriff (PDF)

Effect sizes can be misleading: is it time to change the way we measure change?

Journal of neurology, neurosurgery and psychiatry, 2010-09, Vol.81 (9), p.1044-1048

2010

Volltextzugriff (PDF)

Quality of life measurement after stroke: Uses and abuses of the SF-36

Stroke (1970), 2002-05, Vol.33 (5), p.1348-1356

2002

Volltextzugriff (PDF)

Watch out, watch out, the FDA are about

Developmental medicine and child neurology, 2008-06, Vol.50 (6), p.408-409

2008

Volltextzugriff (PDF)

Modafinil for multiple sclerosis fatigue: Does it work?

Clinical neurology and neurosurgery, 2010-01, Vol.112 (1), p.29-31

2010

Volltextzugriff (PDF)

The size of the treatment effect: do patients and proxies agree?

BMC neurology, 2009-03, Vol.9 (12), p.12-12, Article 12

2009

Volltextzugriff (PDF)

International cooperative ataxia rating scale (ICARS): Appropriate for studies of Friedreich's ataxia?

Movement disorders, 2005-12, Vol.20 (12), p.1585-1591

2005

Volltextzugriff (PDF)

Friedreich's ataxia impact scale: A new measure striving to provide the flexibility required by today's studies

Movement disorders, 2009-05, Vol.24 (7), p.984-992

2009

Volltextzugriff (PDF)

Evidence-based guidelines for using the Short Form 36 in cervical dystonia

Movement disorders, 2007-01, Vol.22 (1), p.122-127

2007

Volltextzugriff (PDF)

Exploring rating scale responsiveness: does the total score reflect the sum of its parts?

Neurology, 2004-05, Vol.62 (10), p.1842

2004

Volltextzugriff (PDF)

Coordinating outcomes measurement in ataxia research: Do some widely used generic rating scales tick the boxes?

Movement disorders, 2006-09, Vol.21 (9), p.1396-1403

2006

Volltextzugriff (PDF)

Socio-demographic variables are limited predictors of health status in multiple sclerosis

Journal of neurology, 2003-09, Vol.250 (9), p.1088-1093

2003

Volltextzugriff (PDF)

Evidence-based measurement: which disability scale for neurologic rehabilitation?

Neurology, 2001-08, Vol.57 (4), p.639

2001

Volltextzugriff (PDF)

Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples

Journal of neurology, neurosurgery and psychiatry, 2002-12, Vol.73 (6), p.701-704

2002

Volltextzugriff (PDF)

Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson’s disease with normal population health profiles

Journal of neurology, neurosurgery and psychiatry, 2003-06, Vol.74 (6), p.710-714

2003

Volltextzugriff (PDF)

1858/An Empirical Demonstration of the Limitations of Classical Test Theory and the Advantages of New Psychometric Methods

Quality of life research, 2003-11, Vol.12 (7), p.744-744

Jeremy C. Hobart

2003

Volltextzugriff (PDF)

1 – 25 von 58

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(55)

Publikationsform

Artikel
(58)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations

Definitions, diagnosis, and decompression in spinal surgery: problems and solution

MUltiple Sclerosis and Extract of Cannabis: results of the MUSEC trial

Patient-orientated longitudinal study of multiple sclerosis in south west England (The South West Impact of Multiple Sclerosis Project, SWIMS) 1: protocol and baseline characteristics of cohort

What sample sizes for reliability and validity studies in neurology?

The ADAS-cog in Alzheimer's disease clinical trials: psychometric evaluation of the sum and its parts

A tool to measure the attributes of receiving IV therapy in a home versus hospital setting: the Multiple Sclerosis Relapse Management Scale (MSRMS)

The problem with health measurement

The cervical dystonia impact profile (CDIP-58): can a Rasch developed patient reported outcome measure satisfy traditional psychometric criteria?

Patient-based outcomes of cervical dystonia: A review of rating scales

Effect sizes can be misleading: is it time to change the way we measure change?

Quality of life measurement after stroke: Uses and abuses of the SF-36

Watch out, watch out, the FDA are about

Modafinil for multiple sclerosis fatigue: Does it work?

The size of the treatment effect: do patients and proxies agree?

International cooperative ataxia rating scale (ICARS): Appropriate for studies of Friedreich's ataxia?

Friedreich's ataxia impact scale: A new measure striving to provide the flexibility required by today's studies

Evidence-based guidelines for using the Short Form 36 in cervical dystonia

Exploring rating scale responsiveness: does the total score reflect the sum of its parts?

Coordinating outcomes measurement in ataxia research: Do some widely used generic rating scales tick the boxes?

Socio-demographic variables are limited predictors of health status in multiple sclerosis

Evidence-based measurement: which disability scale for neurologic rehabilitation?

Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples

Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson’s disease with normal population health profiles

1858/An Empirical Demonstration of the Limitations of Classical Test Theory and the Advantages of New Psychometric Methods

Suchergebnisse filtern